Published in Medical Letter on the CDC and FDA, September 3rd, 2006
Duetact combines Actos(pioglitazone HCl) and glimepiride, two widely used diabetes medications with complementary actions, in a single tablet. Actos directly targets insulin resistance, a condition where the body does not efficiently use the insulin it produces; and glimepiride, a sulfonylurea, acts primarily by increasing the amount of insulin produced by the pancreas. These medications work in combination to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA